August 18, 2023 – Goldea Capital

Lupaka Completes Non-Brokered Private Placement

Written by Customer Service on August 18, 2023. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) — Lupaka Gold Corp. (“Lupaka Gold” or the “Company“) (TSX-V: LPK, FRA: LQP) announces that it has now completed its previously-announced non-brokered private placement (the “Placement”), having raised gross proceeds of $120,000 in two tranches. As of August 18, 2023, the Company has closed Tranche 2 of the Placement and issued 700,000 units at a price of $0.06 per unit for gross proceeds of $42,000. All Shares issued and Warrant shares (if exercised prior to December 19, 2023) are subject to a hold period expiring four months plus one day from the closing date of the second tranche of the Placement in accordance with applicable securities laws. Together with...

Purpose Investments Inc. Announces August 2023 Distributions

Written by Customer Service on August 18, 2023. Posted in Dividend Reports And Estimates.

TORONTO, Aug. 18, 2023 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of August 2023 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all ETFs is August 28, 2023, with the exception of Purpose Bitcoin Yield ETF and Purpose Ether Yield ETF, which will have an ex-distribution date of August 29, 2023, as well as Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund which have an ex-distribution date of August 30, 2023. The ex-distribution date for all closed-end funds is August 30, 2023. Open-End Funds TickerSymbol Distributionpershare/unit RecordDate PayableDate DistributionFrequency Purpose Core Dividend Fund – ETF Series PDF $ 0.10501 08/29/2023 09/08/2023 Monthly Purpose...

Blender Bites Launches into Walmart USA

Written by Customer Service on August 18, 2023. Posted in Public Companies.

Products to Launch in approximately 1,600 stores Across the Nation VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) — Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), a multi award-winning Canadian company involved in the development and marketing of a line of premium, frozen functional beverages, is thrilled to announce its US subsidiary, Blender Bites US Ltd., is launching at Walmart USA (“Walmart”), with product now ready to ship to approximately 1,600 Walmart locations across the U.S. This collaboration marks a significant milestone for the Company, catapulting the Blender Bites’ brand and placing it firmly on the map as a strong player in the frozen beverage category. Blender Bites’ 1-Step Smoothies are a frozen innovation made to simplify the smoothie process,...

EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of Wet Age-related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)

Written by Customer Service on August 18, 2023. Posted in Public Companies.

Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection 2 mg that were maintained with fewer injections First and only treatment approved in wAMD and DME for immediate dosing at 8-week and up to 16-week intervals following three initial monthly doses TARRYTOWN, N.Y., Aug. 18, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD (aflibercept) Injection 8 mg for the treatment of patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy (DR). The recommended dose for EYLEA HD is 8 mg (0.07 mL of 114.3 mg/mL solution) every 4 weeks (monthly) for the first 3 months across all indications,...

Newcore Gold Announces Annual Grant of Equity Incentive Awards

Written by Customer Service on August 18, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) — Newcore Gold Ltd. (“Newcore” or the “Company”) (TSX-V: NCAU, OTCQX: NCAUF) announces the annual grant of equity incentive awards. Newcore has granted 1,540,000 stock options and 531,000 restricted share units (together the “Equity Incentive Awards”) to employees, directors and executives of the Company. The stock options were granted at a price of $0.20 per share for a period of five years. The Equity Incentive Awards are subject to regulatory approval, are granted under the Company’s long-term incentive plan and are subject to vesting provisions. About Newcore Gold Ltd. Newcore Gold is advancing its Enchi Gold Project located in Ghana, Africa’s largest gold producer (1). Newcore Gold offers investors a unique combination of top-tier...

Revival Gold Terminates Royalty Interest

Written by Customer Service on August 18, 2023. Posted in Public Companies.

TORONTO, Aug. 18, 2023 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), is pleased to announce that it has reached an agreement to terminate a 1% Net Smelter Royalty (“NSR”) on sixteen claims (the “HAI and Gold Bug Claims”) that comprised approximately 133 hectares within Revival Gold’s Beartrack-Arnett 5,800 hectare project area. The HAI and Gold Bug Claims were acquired by Revival Gold in 2017 subject to a 1% NSR with an option for the Company to buyback the 1% NSR for a price of US$2 million. The claims are undrilled by Revival Gold and currently host no Mineral Resources. Revival Gold has agreed to deliver the following in exchange for extinguishing the 1% NSR on the HAI and Gold Bug Claims: C$75,000 cash payment on closing (“Closing”); and 200,000 common shares of Revival Gold...

Pacific Health Care Organization, Inc. Reports its Results for the Period ended June 30, 2023

Written by Customer Service on August 18, 2023. Posted in Earnings Releases And Operating Results.

Irvine, Aug. 18, 2023 (GLOBE NEWSWIRE) — Results The Company reported net income of $176,427 or $0.01 per basic and fully diluted common share for the three months ended June 30, 2023, compared to net income of $124,524, or $0.01 per basic and fully diluted common share for the three months ended June 30, 2022. For the first six months of 2023 the Company reported net income of $307,536 or $0.02 per basic and fully diluted common share, compared to net income of $313,059 or $0.02 per basic and fully diluted common share for the first six months of 2022. Total revenues for the three months ended June 30, 2023 was $1,298,894 compared to $1,400,451 for the same period in 2022, a decrease of $101,557 or 7 percent. For the first six months of 2023 the Company recorded total revenue of $2,611,537 compared to total revenues of $2,827,834...

Arcutis Appoints Interim Chief Financial Officer (CFO)

Written by Customer Service on August 18, 2023. Posted in Public Companies.

Former and First Arcutis CFO, John Smither, Appointed Interim WESTLAKE VILLAGE, Calif., Aug. 18, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that John W. Smither, who served as Arcutis’ first Chief Financial Officer (CFO) from 2019 to 2021, has been appointed interim CFO effective August 31. He is replacing Scott Burrows, who is leaving the Company as of such date to pursue an external opportunity. “We are delighted that John has agreed to step in as interim CFO. He brings an incredible depth and breadth of both financial acumen and dermatology experience from his 25+-year career in the pharmaceutical industry, culminating in five successive CFO roles including his previous...

Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results

Written by Customer Service on August 18, 2023. Posted in Public Companies.

MALVERN, Pa., Aug. 18, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that it will host a conference call and live webcast to discuss the Company’s second quarter 2023 financial results and provide a business update at 8:30 a.m. ET on Tuesday, August 22, 2023. Ocugen will issue its 2Q23 financial results on Monday, August 21, 2023. Following the press release, the Company will hold the conference call on Tuesday, August 22 at 8:30 a.m. ET. Attendees are invited to participate in the call using the following details: Dial-in Numbers: (800) 715-9871 for U.S. callers and (646) 307-1963 for international callersConference ID: 6803433Webcast: Available on...

AM Best downgrades credit ratings of United Fire Group, Inc. and its property/casualty subsidiaries to A- (Excellent) with stable outlook

Written by Customer Service on August 18, 2023. Posted in Public Companies.

CEDAR RAPIDS, Iowa, Aug. 18, 2023 (GLOBE NEWSWIRE) — Today, AM Best announced downgrades of the credit ratings of United Fire Group, Inc. (“UFG”) and its property/casualty subsidiaries. Specifically, the Financial Strength Rating was downgraded to A- (Excellent) from A (Excellent), and the Long-Term Issue Credit Ratings (“ICR”) of the property/casualty subsidiaries of UFG to “a-” (Excellent) from “a” (Excellent). Concurrently, AM Best has downgraded the Long-Term ICR to “bbb-” (Good) from “bbb” (Good) of UFG. The outlook of these ratings was revised to stable. See the AM Best press release at news.ambest.com for full commentary. “While we are disappointed with this outcome, we acknowledge that recent years’ financial results have not met our high standards as a company,” said Kevin Leidwinger, President...

Day: August 18, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice